Minervo Perez

Minervo Perez

Auto-generated profile, based on publicly available information

Minervo Perez

Chemical Biology Laboratory, Center for Cancer Research

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Molecular Cell
Verified
Journal Article
Closed access
CNCharles P. Najt
Charles P. Najt
SKSalmaan A. Khan
Salmaan A. Khan
THTimothy D. Heden
Timothy D. Heden
BWBruce A. Witthuhn
Bruce A. Witthuhn
MPMinervo Perez
Minervo Perez
DMDouglas G. Mashek
Douglas G. Mashek

17 February 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ALAndrew M. Lipchik
Andrew M. Lipchik
MPMinervo Perez
Minervo Perez
SBScott Bolton
Scott Bolton
VDVasin Dumrongprechachan
Vasin Dumrongprechachan
SOSteven B. Ouellette
Steven B. Ouellette
LPLaurie L. Parker
Laurie L. Parker

24 July 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
ALAndrew M. Lipchik
Andrew M. Lipchik
MPMinervo Perez
Minervo Perez
WCWei Cui
Wei Cui
LPLaurie L. Parker
Laurie L. Parker

21 March 2025 in Science Advances
Verified
Journal Article
Open access
SGSupuni Thalalla Gamage
Supuni Thalalla Gamage
RKRoxane Khoogar
Roxane Khoogar
SMShereen Howpay Manage
Shereen Howpay Manage
JDJudey T. DaRos
Judey T. DaRos
MCMcKenna C. Crawford
McKenna C. Crawford
JMJordan L. Meier
Jordan L. Meier
Transfer RNA (tRNA) modifications are crucial for protein synthesis, but their position-specific physiological roles remain poorly understood. Here, we investigate the impact of N 4 -acetylcytidine (ac 4 C), a highly conserved tRNA modification catalyzed by the essential acetyltransferase Nat10. By targeting Thumpd1, a nonessential adapter protein required for Nat10-catalyzed tRNA acetylation, we determine that loss of tRNA acetylation leads to reduced levels of tRNA Leu , increased ribosome stalling, and activation of eIF2α phosphorylation. Thumpd1 knockout mice exhibit growth defects and sterility. Concurrent knockout of Thumpd1 and the stress-sensing kinase Gcn2 causes penetrant postnatal lethality in mice, indicating a critical genetic interaction. Our findings demonstrate that a modification restricted to a single position within type II cytosolic tRNAs can regulate ribosome-mediated stress signaling in mammalian organisms, with implications for our understanding of translational control and therapeutic interventions.

1 March 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
MPMinervo Perez
Minervo Perez
JBJohn Blankenhorn
John Blankenhorn
KMKevin J. Murray
Kevin J. Murray
LPLaurie L. Parker
Laurie L. Parker
Acute myeloid leukemia (AML) is an aggressive disease that is characterized by abnormal increase of immature myeloblasts in blood and bone marrow. The FLT3 receptor tyrosine kinase plays an integral role in hematopoiesis, and one third of AML diagnoses exhibit gain-of-function mutations in FLT3, with the juxtamembrane domain internal tandem duplication (ITD) and the kinase domain D835Y variants observed most frequently. Few FLT3 substrates or phosphorylation sites are known, which limits insight into FLT39s substrate preferences and makes assay design particularly challenging. We applied in vitro phosphorylation of a cell lysate digest (adaptation of the Kinase Assay Linked with Phosphoproteomics (KALIP) technique and similar methods) for high-throughput identification of substrates for three FLT3 variants (wild-type, ITD mutant, and D835Y mutant). Incorporation of identified substrate sequences as input into the KINATEST-ID substrate preference analysis and assay development pipeline facilitated the design of several peptide substrates that are phosphorylated efficiently by all three FLT3 kinase variants. These substrates could be used in assays to identify new FLT3 inhibitors that overcome resistant mutations to improve FLT3-positive AML treatment. Graphical Abstract Highlights Developed a data processing pipeline to format phosphopeptide identifications. Identified the preferred substrate motif for FLT3 and mutant kinases. Designed and validated a panel of pan-FTL3 artificial substrates. Monitored FLT3 and mutant kinase activity through FAStide phosphorylation.

1 September 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MPMinervo Perez
Minervo Perez
DBDaniel W. Bak
Daniel W. Bak
SBSarah E. Bergholtz
Sarah E. Bergholtz
DCDaniel R. Crooks
Daniel R. Crooks
BABhargav Srinivas Arimilli
Bhargav Srinivas Arimilli
JMJordan L. Meier
Jordan L. Meier
An important context in which metabolism influences tumorigenesis is the genetic cancer syndrome hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a disease in which mutation of the TCA cycle enzyme fumarate hydratase (FH) causes hyperaccumulation of fumarate. This electrophilic oncometabolite can alter gene activity at the level of transcription, via reversible inhibition of epigenetic dioxygenases, as well as posttranslationally, via covalent modification of cysteine residues. To better understand the potential for metabolites to influence posttranslational modifications important to tumorigenesis and cancer cell growth, here we report a chemoproteomic analysis of a kidney-derived HLRCC cell line. Using a general reactivity probe, we generated a dataset of proteomic cysteine residues sensitive to the reduction in fumarate levels caused by genetic re-introduction of active FH into HLRCC cell lines. This revealed a broad upregulation of cysteine reactivity upon FH rescue, which evidence suggests is caused by an approximately equal proportion of transcriptional and posttranslational modification-mediated regulation. Gene ontology analysis highlighted several new targets and pathways potentially modulated by FH mutation. Comparison of the new dataset to prior studies highlights considerable heterogeneity in the adaptive response of cysteine-containing proteins in different models of HLRCC. This is consistent with emerging studies indicating the existence of cell and tissue-specific cysteine-omes, further emphasizing the need for characterization of diverse models. Our analysis provides a resource for understanding the proteomic adaptation to fumarate accumulation, and a foundation for future efforts to exploit this knowledge for cancer therapy.